Lu XJ - Search Results

1

Applications and advances of CRISPR-Cas9 in cancer immunotherapy.

Xia AL, He QF, Wang JC, Zhu J, Sha YQ, Sun B, Lu XJ. Xia AL, et al. Among authors: lu xj. J Med Genet. 2019 Jan;56(1):4-9. doi: 10.1136/jmedgenet-2018-105422. Epub 2018 Jul 3. J Med Genet. 2019. PMID: 29970486 Review.

2

Modeling cancer processes with CRISPR-Cas9.

Lu XJ, Qi X, Zheng DH, Ji LJ. Lu XJ, et al. Trends Biotechnol. 2015 Jun;33(6):317-9. doi: 10.1016/j.tibtech.2015.03.007. Epub 2015 Apr 20. Trends Biotechnol. 2015. PMID: 25908505

3

CRISPR screen: a high-throughput approach for cancer genetic research.

Lu XJ, Xiang YY, Li XJ. Lu XJ, et al. Clin Genet. 2015 Jul;88(1):32-3. doi: 10.1111/cge.12606. Epub 2015 May 25. Clin Genet. 2015. PMID: 25955354 No abstract available.

4

CRISPR-Cas9 for medical genetic screens: applications and future perspectives.

Xue HY, Ji LJ, Gao AM, Liu P, He JD, Lu XJ. Xue HY, et al. Among authors: lu xj. J Med Genet. 2016 Feb;53(2):91-7. doi: 10.1136/jmedgenet-2015-103409. Epub 2015 Dec 16. J Med Genet. 2016. PMID: 26673779 Review.

5

The applications and advances of CRISPR-Cas9 in medical research.

Lu XJ, Sun HM, Xu Y, Yu X, Gu B. Lu XJ, et al. Brief Funct Genomics. 2017 Jan;16(1):1-3. doi: 10.1093/bfgp/elw036. Brief Funct Genomics. 2017. PMID: 28132023 No abstract available.

6

The pros and cons of dying tumour cells in adaptive immune responses.

Wang X, Lu XJ, Sun B. Wang X, et al. Among authors: lu xj. Nat Rev Immunol. 2017 Sep;17(9):591. doi: 10.1038/nri.2017.87. Epub 2017 Jul 31. Nat Rev Immunol. 2017. PMID: 28757605 No abstract available.

7

Pitfalls in the non-invasive assessment of liver fibrosis with eLIFT-FM^VCTE algorithm.

Wang XC, Zhang XY, Zhang X, Yuan ZX, Li XH, Wang JC, Sun B, Lu XJ. Wang XC, et al. Among authors: lu xj. J Hepatol. 2018 Mar;68(3):602-603. doi: 10.1016/j.jhep.2017.08.038. Epub 2017 Oct 6. J Hepatol. 2018. PMID: 28993184 No abstract available.

8

Towards In Silico Prediction of the Immune-Checkpoint Blockade Response.

Chen K, Ye H, Lu XJ, Sun B, Liu Q. Chen K, et al. Among authors: lu xj. Trends Pharmacol Sci. 2017 Dec;38(12):1041-1051. doi: 10.1016/j.tips.2017.10.002. Epub 2017 Oct 28. Trends Pharmacol Sci. 2017. PMID: 29089139 Review.

9

Assessment of liver fibrosis with the gamma-glutamyl transpeptidase to platelet ratio: a multicentre validation in patients with HBV infection.

Lu XJ, Li XH, Yuan ZX, Sun HY, Wang XC, Qi X, Zhang X, Sun B. Lu XJ, et al. Gut. 2018 Oct;67(10):1903-1904. doi: 10.1136/gutjnl-2017-315299. Epub 2017 Nov 3. Gut. 2018. PMID: 29101263 No abstract available.

10

Chimeric-antigen receptor T (CAR-T) cell therapy for solid tumors: challenges and opportunities.

Xia AL, Wang XC, Lu YJ, Lu XJ, Sun B. Xia AL, et al. Among authors: lu xj, lu yj. Oncotarget. 2017 Jul 18;8(52):90521-90531. doi: 10.18632/oncotarget.19361. eCollection 2017 Oct 27. Oncotarget. 2017. PMID: 29163850 Free PMC article. Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

480 results

Search Page

Filters